BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 31, 2008
View Archived Issues
Snapshots on the GlaxoSmithKline's antimalarial vaccines under clinical development in children
Read More
Recent clinical study results for anticoagulant DU-176b
Read More
Recent patents impart novel anticancer agents
Read More
TorreyPines describes new agents for Alzheimer's disease in recent patent
Read More
Dr. Reddy's patents novel antibacterial agents
Read More
Novocell and Pfizer enter collaboration for pancreatic progenitor cells derived from hES cells
Read More
Development of TPI-1020 in COPD discontinued
Read More
Oncolytics completes patient enrollment in REO-010 and REO-008 clinical trials of Reolysin
Read More
Pfizer and Celldex amend ACT III phase Ib/III clinical trial of CDX-110 in GBM
Read More
Genmab and GSK amend worldwide agreement to codevelop and commercialize Arzerra
Read More
AMAG receives complete response letter from FDA for ferumoxytol in kidney disease
Read More
TopoTarget reports further results from three phase II studies of NAD+ inhibitor APO-866
Read More
Phase II study of catumaxomab in gastric cancer meets primary endpoint
Read More
Evolva files CTA in Germany for phase I study of EV-077-3201-2TBS
Read More
BioCryst reports data for forodesine HCl in chronic lymphocytic leukemia
Read More
NPS commences phase III REPLACE study for NPSP-558 in hypoparathyroidism
Read More
Sanofi-aventis presents results from DIONYSOS trial in atrial fibrillation
Read More
AstraZeneca receives complete response letter for Seroquel XR for MDD
Read More
Northwest reports positive results from phase I/II clinical of DCVax-L in ovarian cancer
Read More
European Commission grants marketing authorization to Celgene's Vidaza in MDS and AML
Read More
Neuren discontinues Glypromate development following pivotal trial
Read More
Intercell initiates phase II trial for Pseudomonas aeruginosa vaccine
Read More
King commences phase II T-62 trial in neuropathic pain
Read More
Phase I study shows HA-22 highly active in hairy cell leukemia
Read More
Celsentri tablets approved in Japan for HIV
Read More
Addition of BSI-201 to gemcitabine/carboplatin feasible in triple negative breast cancer
Read More
Phase I and II data on trastuzumab-DM1 in HER2+ breast cancer reported
Read More